Mark Stanley Berger, CMO at Actinium Pharmaceuticals, holds 4.81K shares in Genprex (Ticker: GNPX), holds 22.50K shares in Actinium Pharmaceuticals (Ticker: ATNM).

See the Hottest Stocks Based on Insider Trading >

Mark Stanley Berger
Actinium Pharmaceuticals (ATNM)
CMO

Ranked #83,176 out of 98,624 Corporate Insiders

Profitable Transactions

0 out of 2 Profitable Transactions

Average Return

-52.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

93.57%

ATNM

6.43%

GNPX

A breakdown of Mark Stanley Berger's holdings

See the Top Stocks by Insiders

Insider Roles

Actinium Pharmaceuticals
(ATNM)

CMO

Genprex
(GNPX)

CMO

Roles that Mark Stanley Berger holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Actinium Pharmaceuticals
(ATNM)

Rating:Informative Buy

Date:Mar 07, 2019 - Mar 07, 2020

Return:-49.30%

The most profitable trade made by Mark Stanley Berger

See the Latest Stocks Traded by Insiders

Mark Stanley Berger's Trading History

ATNM

Actinium Pharmaceuticals

Mar 07, 2019

CMO

Informative Buy

2.10K

$154.57K

GNPX

Genprex

Feb 21, 2024

CMO

Uninformative Sell

5.80K

$10.62K

List of latest transactions for each holding click on a transaction to see Mark Stanley Berger's performance on stock

See All Insider Trading from Today

Mark Stanley Berger insider profile FAQ

What is the percentage of profitable transactions made by Mark Stanley Berger?

The percentage of profitable transactions made by Mark Stanley Berger is 0%.

What is the average return per transaction made by Mark Stanley Berger?

The average return per transaction made by Mark Stanley Berger is -52.90%.

What stocks does Mark Stanley Berger hold?

Mark Stanley Berger holds: ATNM, GNPX stocks.

What was Mark Stanley Berger’s latest transaction?

Mark Stanley Berger latest transaction was an Uninformative Sell of $5.80K.

What was Mark Stanley Berger's most profitable transaction?

Mark Stanley Berger’s most profitable transaction was an Informative Buy of ATNM stock on March 7, 2019. The return on the trade was -49.30%.

What is Mark Stanley Berger's role in Actinium Pharmaceuticals?

Mark Stanley Berger's role in Actinium Pharmaceuticals is CMO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Mark Stanley Berger Insider Profile

Mark Stanley Berger Actinium Pharmaceuticals (ATNM)CMO